{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:25:09Z","timestamp":1783571109417,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009776","name":"McMaster University","doi-asserted-by":"publisher","award":["NCT02096289"],"award-info":[{"award-number":["NCT02096289"]}],"id":[{"id":"10.13039\/100009776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["706694"],"award-info":[{"award-number":["706694"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.xcrm.2021.100202","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T15:06:42Z","timestamp":1613574402000},"page":"100202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients"],"prefix":"10.1016","volume":"2","author":[{"given":"Lili","family":"Aslostovar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick D.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Di Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Garcia Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna P.","family":"Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Leber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anargyros","family":"Xenocostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickie","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2021.100202_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/medicina55080414","article-title":"Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology","volume":"55","author":"Crisci","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.xcrm.2021.100202_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/ajh.25214","article-title":"Acute myeloid leukemia: 2019 update on risk-stratification and management","volume":"93","author":"Estey","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.xcrm.2021.100202_bib3","first-page":"748","article-title":"Moving toward targeted therapies in acute myeloid leukemia","volume":"13","author":"Gao","year":"2015","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2021.100202_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/jpm2010015","article-title":"Trends in Personalized Therapies in Oncology: The (Venture) Capitalist\u2019s Perspective","volume":"2","author":"Fleck","year":"2012","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.xcrm.2021.100202_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/2040620714532123","article-title":"The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond","volume":"5","author":"Wander","year":"2014","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.xcrm.2021.100202_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature13283","article-title":"The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation","volume":"511","author":"Zahreddine","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100202_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1126\/science.1825731","article-title":"D1 dopamine receptors in prefrontal cortex: involvement in working memory","volume":"251","author":"Sawaguchi","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100202_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/j.1552-4604.1992.tb03788.x","article-title":"Comparative effects of dopaminergic agonists on cardiovascular, renal, and renin-angiotensin systems in hypertensive patients","volume":"32","author":"Luchsinger","year":"1992","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.xcrm.2021.100202_bib9","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.174.4016.1346","article-title":"Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission","volume":"174","author":"Kebabian","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100202_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100202_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100202_bib12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100202_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ccell.2016.05.002","article-title":"Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells","volume":"29","author":"Dolma","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2021.100202_bib14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nn.4088","article-title":"EAG2 potassium channel with evolutionarily conserved function as a brain tumor target","volume":"18","author":"Huang","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2021.100202_bib15","doi-asserted-by":"crossref","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","article-title":"Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data","volume":"6","author":"Cheng","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2021.100202_bib16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2021.100202_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","article-title":"Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL","volume":"22","author":"Nagel","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2021.100202_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2021.100202_bib19","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/bloodadvances.2018015677","article-title":"A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia","volume":"2","author":"Aslostovar","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2021.100202_bib20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2021.100202_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1440-1614.2002.01045.x","article-title":"Cardiotoxicity and prescription of thioridazine in New Zealand","volume":"36","author":"Menkes","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.xcrm.2021.100202_bib22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2013.085209","article-title":"Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials","volume":"99","author":"Pollyea","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2021.100202_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2021.100202_bib24","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100202_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","article-title":"Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence","volume":"34","author":"Boyd","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2021.100202_bib26","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/bloodadvances.2017009829","article-title":"The role of targeted therapy in the management of patients with AML","volume":"1","author":"Perl","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2021.100202_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100202_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.beem.2018.01.004","article-title":"Internalization of G-protein-coupled receptors: implication in receptor function, physiology and diseases","volume":"32","author":"Calebiro","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2021.100202_bib29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/npp.2009.189","article-title":"Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers","volume":"35","author":"Guo","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.xcrm.2021.100202_bib30","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1096\/fj.201600755RR","article-title":"Functional expression of dopamine D2 receptor is regulated by tetraspanin 7-mediated postendocytic trafficking","volume":"31","author":"Lee","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.xcrm.2021.100202_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2010.01.055","article-title":"D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model","volume":"50","author":"Skinbjerg","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.xcrm.2021.100202_bib32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.283.5403.845","article-title":"Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4","volume":"283","author":"Peled","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100202_bib33","doi-asserted-by":"crossref","first-page":"14626","DOI":"10.1073\/pnas.97.26.14626","article-title":"The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression","volume":"97","author":"Rosu-Myles","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100202_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12885-017-3352-z","article-title":"Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma","volume":"17","author":"Sand","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2021.100202_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(83)90452-1","article-title":"Neuroleptics have identical potencies in human brain limbic and putamen regions","volume":"94","author":"Seeman","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2021.100202_bib36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1210\/en.2012-1759","article-title":"Dopamine inhibits reproduction in female zebrafish (Danio rerio) via three pituitary D2 receptor subtypes","volume":"154","author":"Fontaine","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2021.100202_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.xcrm.2021.100202_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2012.07.025","article-title":"Chemoenzymatic synthesis and evaluation of 3-azabicyclo[3.2.0]heptane derivatives as dopaminergic ligands","volume":"55","author":"Reinart-Okugbeni","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.xcrm.2021.100202_bib39","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1172\/JCI114371","article-title":"Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat","volume":"84","author":"Kinoshita","year":"1989","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2021.100202_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng1305","article-title":"Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation","volume":"36","author":"Stegmaier","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2021.100202_bib41","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1073\/pnas.86.8.2849","article-title":"Induction of megakaryocytic differentiation and modulation of protein kinase gene expression by site-selective cAMP analogs in K-562 human leukemic cells","volume":"86","author":"Tortora","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100202_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(98)00227-1","article-title":"Forskolin induces U937 cell line differentiation as a result of a sustained cAMP elevation","volume":"350","author":"Brodsky","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2021.100202_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nmeth.2847","article-title":"Identification of small molecules that support human leukemia stem cell activity ex\u00a0vivo","volume":"11","author":"Pabst","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2021.100202_bib44","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0028-3908(88)90006-8","article-title":"Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: evidence for different stereoselectivities at D1 and D2 receptors in rat brain","volume":"27","author":"Svendsen","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xcrm.2021.100202_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0379-0738(94)90227-5","article-title":"Thioridazine enantiomers in human tissues","volume":"64","author":"Jortani","year":"1994","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.xcrm.2021.100202_bib46","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/bjp.2008.267","article-title":"Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model","volume":"154","author":"Yao","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2021.100202_bib59","doi-asserted-by":"crossref","first-page":"180061","DOI":"10.1038\/sdata.2018.61","article-title":"Unifying cancer and normal RNA sequencing data from different sources","volume":"5","author":"Wang","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.xcrm.2021.100202_bib47","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1038\/onc.2015.369","article-title":"Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer","volume":"35","author":"Borcherding","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2021.100202_bib48","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2015-01-561373","article-title":"Current challenges in clinical development of \u201ctargeted therapies\u201d: the case of acute myeloid leukemia","volume":"125","author":"Estey","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100202_bib49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100202_bib50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature13824","article-title":"Clonal dynamics of native haematopoiesis","volume":"514","author":"Sun","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100202_bib51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2013.12.012","article-title":"Dynamics of HSPC repopulation in nonhuman primates revealed by a decade-long clonal-tracking study","volume":"14","author":"Kim","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2021.100202_bib52","first-page":"527","article-title":"Ultrastructural and morphometric alterations in bone marrow stromal tissue after 7\u00a0Gy irradiation","volume":"17","author":"Yamazaki","year":"1991","journal-title":"Blood Cells"},{"key":"10.1016\/j.xcrm.2021.100202_bib53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nature06185","article-title":"Phagocyte-derived catecholamines enhance acute inflammatory injury","volume":"449","author":"Flierl","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100202_bib54","first-page":"222","article-title":"Blood bioamines, cortisol and aminoacid levels in leukemic patients","volume":"26","author":"Singh","year":"1989","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.xcrm.2021.100202_bib55","first-page":"1543","article-title":"Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis","volume":"8","author":"Lu","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.xcrm.2021.100202_bib56","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100202_bib57","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2008-06-161539","article-title":"CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure","volume":"113","author":"Fiegl","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100202_bib58","doi-asserted-by":"crossref","first-page":"107684","DOI":"10.1016\/j.celrep.2020.107684","article-title":"CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia","volume":"31","author":"Ramakrishnan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2021.100202_bib60","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1084\/jem.20140131","article-title":"Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs","volume":"211","author":"Boyd","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2021.100202_bib61","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/stem.1994","article-title":"Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations","volume":"33","author":"Salci","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.xcrm.2021.100202_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","article-title":"Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia","volume":"10","author":"Somervaille","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2021.100202_bib63","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3324\/haematol.2009.005967","article-title":"Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells","volume":"94","author":"Langenkamp","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2021.100202_bib64","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/BC20090060","article-title":"Integrin alpha8beta1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA\/ROCK-dependent mechanism","volume":"101","author":"Benoit","year":"2009","journal-title":"Biol. Cell"},{"key":"10.1016\/j.xcrm.2021.100202_bib65","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:13:33Z","timestamp":1778919213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379121000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2666379121000136"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100202","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021","name":"copyright","label":"Copyright"}],"article-number":"100202"}}